Latest profit margin for Mylan N.V.: 2.31% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2020
Trailing 12 months ending Sep 2020
Mylan N.V. (MYL) currently reports a profit margin of 2.31% as of September 2020. That compares with 0.42% in the prior-year period — up 454.7% year over year. That is below the Healthcare sector average of 13.71%. Use the charts on this page to explore Mylan N.V.'s profit margin history and peer comparisons.
Mylan N.V.'s profit margin increased from 0.42% to 2.31% — a 454.7% year-over-year increase (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Mylan N.V.'s profit margin of 2.31% is lower than the Healthcare sector average of 13.71%. That is roughly 83.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Mylan N.V.'s current 2.31% should be judged against Healthcare norms (sector average: 13.71%) and against MYL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 2.31%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.71%. From there, open related valuation or income-statement pages for Mylan N.V., and consider following MYL for alerts when major investors trade the stock.